Liaison Tech partners with SAFE-BioPharma Association

Monday, February 13, 2012 03:06 PM

Liaison Technologies, a global provider of secure cloud-based integration and data management services, has partnered with the SAFE-BioPharma Association.

Through the partnership, Liaison’s clients and their partners can leverage the validation and security of the SAFE-BioPharma standard, which verifies and manages digital identities and signatures involved in electronic transactions.

“Liaison’s enablement of the SAFE-BioPharma standard in a cloud-based platform is important to life sciences organizations as they utilize this important technology,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. 

The standard was designed to speed transformation of the biopharmaceutical and healthcare communities to a fully digital environment, while mitigating legal, regulatory and other business risks associated with electronic transactions. Recognized by the DEA and in line with HIPAA regulations, the standard provides a way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions.

“Collaborating with SAFE-BioPharma shows an ongoing commitment to ensuring our cloud-based services are supported by industry standards that enhance the quality and security of patient and other sensitive data,” said Gary Palgon, Liaison’s vice president of healthcare solutions.

Earlier this year, Liaison announced a healthcare partner program in an effort to expand services available to clients so they can more easily exchange information in light of the HITECH Act and new models of care.

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs